A fusion protein, ID93 is a multi-stage antigen, comprising of virulent antigen (Rv2608, Rv3619, Rv3620) and a latent antigen (Rv1813).

We have fused selected proteins through bioinformatical analysis, maintaining the merits of subunit vaccine such as safety and purity, and increasing the efficacy by combining a GLA adjuvant.